Added to basket
Are you sure?
Why did you launch AQ Skin Solutions?
AQ was launched in 2010 from an idea I developed while completing my training at the University of California, Irvine. My goal was to create a unique, science-based skincare line that could help fund my broader research into drugs and medical devices designed to improve people’s lives.
We started with a budget of just $2,000, which covered formally establishing the company and producing the first 50 units of AQ Active Serum. Those initial units were sent to clinics to test the concept, and establish a potential sales channel.
Every clinic that tested the product went on to place a purchase order, giving the company the revenue and momentum to grow. From that modest beginning, AQ evolved into a globally recognised, scienceled skincare brand with an extensive history of product development and international distribution.
What are your aims and aspirations for the brand?
I wanted AQ to stand apart from what was already available in the market. From the beginning, my vision was for the brand to be driven not by hype or pseudoscience, but by credible science, proven innovation, and a strong commitment to safety. AQ’s uniqueness lies in the science behind its products, rather than in colours or packaging. That was the original philosophy when I created the brand, and it remains at the heart of AQ today.
What are the standout products and why?
A standout product in the line is Endo-Test, a hormone free topical formulation developed for both men and women. The concept behind Endo-Test is to use targeted peptide signalling to support the proteins involved in natural testosterone production, rather than supplying testosterone directly.
That conversation has become increasingly relevant as awareness of hormonal health has grown, particularly around menopause. Testosterone is often associated with men, but it also has an important role in women’s physical and sexual health. Greater discussion of persistent low sexual desire during menopause has helped bring this into focus.
For me, Endo-Test represents AQ’s commitment to exploring emerging science and developing products around specific biological pathways. The greater awareness as to how testosterone plays such in important part in both ladies and men brings Endo-Test firmly into the conversation.
What are your best-sellers?
AQ Recovery Serum is one of our best-known professional products. We developed it to complement aesthetic procedures by supporting the skin’s natural recovery processes and helping to soothe post-treatment irritation.
It is our most concentrated formulation, described in our UK product information as a 60 per cent growthfactor formula, and incorporates AQ’s proprietary, patented growth-factor technology. Its purpose is to help improve the appearance of damaged and post-procedure skin, including visible redness, while supporting a more comfortable recovery.
Practitioners use Recovery Serum alongside treatments such as laser resurfacing, microneedling and chemical peels, and within selected post-operative care protocols. The choice of application should always reflect the procedure, the condition of the skin and the treating professional’s assessment.
Recovery Serum has also been investigated in published clinical research. A small study involving fractional CO2 laser treatment of mature facial burn scars, reported shorter downtime on the side treated with the serum, than the side treated with laser alone.
That is encouraging, although recovery varies with the treatment and the individual, so I would avoid promising every patient a fixed percentage reduction.
Which ingredients are you championing at the moment?
We continue to focus on exploring growth factors across a range of indications and applications, particularly in combination with different treatment modalities. We are also evaluating combinations of peptides and growth factors to determine how these approaches may complement one another.
We believe there is considerable potential to integrate these discoveries with our existing technology, expanding our range and further improving the outcomes we can offer.
Who are your key customers?
We are fortunate to have a wide range of professionals using our products. Among them are plastic surgeons, dermatologists and aesthetic doctors, and skin specialist professionals. In some countries, dentists are allowed
to conduct aesthetic procedures, and they make a good portion of our clients.
"AQ’s uniqueness lies in the science behind its products, rather than in colours or packaging"
What are you currently working on?
We have been developing a brand-new lip product for the AQ line for the past three years. During that time, we have refined multiple formulations and carried out testing to evaluate efficacy and safety.
The product represents a new application of our growth factor technology, with a focus on hydration, conditioning and a noticeable plumping effect, while maintaining a premium, comfortable feel. After extensive development and refinement, we expect to launch it in 2027.
What’s 2027 looking like for AQ Skin Solutions?
We will continue to provide our customers with the high level of service they have come to expect, while further refining and expanding our product portfolio. We are especially excited to launch our new lip product across our global network.
We will also participate in the Wigmore Presents conference for the first time, following our agreement with Wigmore Medical to represent AQ Skin Solutions in the UK. It is an exciting time for AQ, and we look forward to building a strong and fruitful partnership with Wigmore Medical.
